pimozide has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, C; Deng, H; Guan, Z; Li, B; Li, Y; Ni, H; Wang, L | 1 |
| Ai, Y; Chen, J; Dexheimer, TS; Inglese, J; Jadhav, A; Liang, Q; Maloney, DJ; Simeonov, A; Villamil, MA; Zhuang, Z | 1 |
2 other study(ies) available for pimozide and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A novel drug repurposing approach for non-small cell lung cancer using deep learning.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Computational Biology; Deep Learning; Drug Discovery; Drug Repositioning; Gene Expression Profiling; Humans; Pimozide; Transcriptome | 2020 |
Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Arabidopsis Proteins; Butyrates; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Repair; Drug Resistance, Neoplasm; Endopeptidases; Fanconi Anemia; Humans; Kinetics; Nuclear Proteins; Phenylurea Compounds; Pimozide; Ubiquitin; Ubiquitin-Specific Proteases | 2011 |